How can we navigate COVID-19 in a new winter health landscape?

What is the waiver impact on innovation and pandemic preparedness?

Why is a therapeutics waiver extension different to the vaccine waiver?

What would a TRIPS waiver extension mean for diagnostics?

What would be the impact of a TRIPS waiver extension?

How can we support medical innovation in Europe?

How can the EU be better prepared for cross-border health threats?

What is needed from the EMA to be better prepared for future health threats?

What is needed from the ECDC to be better prepared for future health threats?

How is precision medicine transforming cancer care?

From raw materials to patients’ arms – how are COVID-19 vaccines made?

How is the pharmaceutical industry contributing to a healthy environment?

How can we improve healthcare access for marginalised communities?

What value do Public Private Partnerships bring for society?

How can vaccines help in Europe's fight against cancer?

Should Europe relocate pharmaceutical production to within the EU?

How can monoclonal antibodies help in the fight against COVID-19?

Is intellectual property a barrier to access?

How can we future-proof medicines regulation in the post-COVID world?

Fighting the fakes - what's industry's role?